Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient‐reported outcome measures-Reference-Cited by-同舟云学术

Dupilumab treatment in patients with atopic dermatitis: a comparative cohort study between the Netherlands and Japan shows a discrepancy in patient‐reported outcome measures

Published:2021-06-08 Issue:3 Volume:185 Page:555-562
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

de Wijs L.E.M.¹^ORCID,Fujimoto R.F.T.²,Andrinopoulou E.R.³^ORCID,Nijsten T.¹^ORCID,Hijnen D.¹^ORCID,Kataoka Y.²^ORCID

Affiliation:

1. Department of Dermatology Erasmus MC University Medical Center Rotterdamthe Netherlands

2. Department of Dermatology Osaka Habikino Medical Center Habikino Osaka Japan

3. Department of Biostatistics Erasmus MC University Medical Center Rotterdam the Netherlands

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.19897

Reference22 articles.

1. Efficacy and safety of dupilumab in Japanese adults with moderate‐to‐severe atopic dermatitis: a subanalysis of three clinical trials

2. Racial differences in atopic dermatitis

3. Atopic dermatitis in diverse racial and ethnic groups-Variations in epidemiology, genetics, clinical presentation and treatment

4. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization

5. Japanese-Specific Filaggrin Gene Mutations in Japanese Patients Suffering from Atopic Eczema and Asthma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses;Dermatologic Therapy;2022-10-20

3. Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab;Acta Dermato-Venereologica;2022-06-09

4. Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis;Dermatologic Therapy;2022-03-03

5. Regional differences between Japan and the Netherlands in atopic dermatitis patient‐reported outcome measures: which interpretation?;British Journal of Dermatology;2021-05-31